Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: Recovery of memory Treg homeostasis during disease progression

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 6411-6420

  Venken, Koen ^a   Hellings, Niels ^a   Broekmans, Tom ^a,b   Hensen, Karen ^c   Rummens, Jean Luc ^c   Stinissen, Piet ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b Arts and Architecture   (Belgium)

^c VIRGA JESSE HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD31 ANTIGEN; GLATIRAMER; INTERLEUKIN 7 RECEPTOR; T LYMPHOCYTE RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL MATURATION; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FLUORESCENCE ACTIVATED CELL SORTING; HOMEOSTASIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; CONVALESCENCE; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; THYMUS; TIME;

ADULT; ANTIGENS, CD; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL; RECOVERY OF FUNCTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TIME FACTORS;

EID: 44449171488     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.6411     Document Type: Article

References (47)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352.
2. Baecher-Allan, C., and D. A. Hafler. 2006. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 212: 203-216. (Pubitemid 44116710)
3. Torgerson, T. R. 2006. Regulatory T cells in human autoimmune diseases. Springer Semin. Immunopathol. 28: 63-76. (Pubitemid 44267960)
4. high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178: 2579-2588.
5. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
6. + regulatory T cells. Nat. Immunol. 4: 330-336.
7. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
8. + Treg cells. J. Exp. Med. 203: 1701-1711.
9. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203: 1693-1700. (Pubitemid 44036275)
10. + chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319: 41-52.
11. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962. (Pubitemid 40979735)
12. Fritzsching, B., N. Oberle, E. Pauly, R. Geffers, J. Buer, J. Poschl, P. Krammer, O. Linderkamp, and E. Suri-Payer. 2006. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108: 3371-3378.
13. + regulatory T cells in adult life. Blood 107: 2830-2838.
14. high regulatory T cells increases with age. Clin. Exp. Immunol. 140: 540-546.
15. Rosenkranz, D., S. Weyer, E. Tolosa, A. Gaenslen, D. Berg, T. Leyhe, T. Gasser, and L. Stoltze. 2007. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J. Neuroimmunol. 188: 117-127. (Pubitemid 47095016)
16. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116: 2423-2433.
17. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199: 971-979.
18. high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35: 3343-3352.
19. + regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 83: 1432-1446.
20. Huan, J., N. Culbertson, L. Spencer, R. Bartholomew, G. G. Burrows, Y. K. Chou, D. Bourdette, S. F. Ziegler, H. Offner, and A. A. Vandenbark. 2005. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81: 45-52. (Pubitemid 41139109)
21. high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123: 79-89.
22. McDonald, W. I., A. Compston, G. Edan, D. Goodkin, H. P. Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H. Polman, S. C. Reingold, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50: 121-127. (Pubitemid 32591472)
23. + regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J. Immunol. Methods 322: 1-11.
24. Thewissen, M., V. Somers, K. Venken, L. Linsen, P. Van Paassen, P. Geusens, J. Damoiseaux, and P. Stinissen. 2007. Analyses of immunosenescent markers in patients with autoimmune disease. Clin. Immunol. 123: 209-218. (Pubitemid 46590073)
25. null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J. Immunol. 179: 6514-6523.
26. Rowen, L., B. F. Koop, and L. Hood. 1996. The complete 685-kilobase DNA sequence of the human β T cell receptor locus. Science 272: 1755-1762. (Pubitemid 26256389)
27. Akbar, A. N., and J. M. Fletcher. 2005. Memory T cell homeostasis and senescence during aging. Curr. Opin. Immunol. 17: 480-485. (Pubitemid 41207950)
28. Kimmig, S., G. K. Przybylski, C. A. Schmidt, K. Laurisch, B. Mowes, A. Radbruch, and A. Thiel. 2002. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195: 789-794. (Pubitemid 34259723)
29. de Andres, C., C. Aristimuno, V. de Las Heras, M. L. Martinez-Gines, M. Bartolome, R. Arroyo, J. Navarro, S. Gimenez-Roldan, E. Fernandez-Cruz, and S. Sanchez-Ramon. 2007. Interferon β-1a therapy enhances CD4β regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 182: 204-211. (Pubitemid 46026708)
30. + regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. USA 102: 6449-6454.
31. + T cells in thymus, cord, and adult blood. Immunology 106: 190-199.
32. + stage, before the onset of functional maturation. J. Immunol. 159: 5973-5983.
33. Hazenberg, M. D., M. C. Verschuren, D. Hamann, F. Miedema, and J. J. van Dongen. 2001. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J. Mol. Med. 79: 631-640. (Pubitemid 33071151)
34. Duszczyszyn, D. A., J. D. Beck, J. Antel, A. Bar-Or, Y. Lapierre, V. Gadag, and D. G. Haegert. 2006. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Clin. Exp. Immunol. 143: 305-313.
35. Haas, J., B. Fritzsching, P. Trubswetter, M. Korporal, L. Milkova, B. Fritz, D. Vobis, P. H. Krammer, E. Suri-Payer, and B. Wildemann. 2007. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J. Immunol. 179: 1322-1330.
36. Hug, A., M. Korporal, I. Schroder, J. Haas, K. Glatz, B. Storch-Hagenlocher, and B. Wildemann. 2003. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J. Immunol. 171: 432-437. (Pubitemid 36745317)
37. Hafler, D. A., A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, A. J. Ivinson, et al. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357: 851-862. (Pubitemid 47347319)
38. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Backstrom, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431. (Pubitemid 46559831)
39. + regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
40. Hohol, M. J., E. J. Orav, and H. L. Weiner. 1999. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult. Scler. 5: 349-354. (Pubitemid 29505050)
41. Rovaris, M., C. Confavreux, R. Furlan, L. Kappos, G. Comi, and M. Filippi. 2006. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol. 5: 343-354.
42. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747. (Pubitemid 40563183)
43. + regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J. Immunol. 175: 32-36.
44. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31: 1122-1131.
45. Weiner, H. L. 2001. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182: 207-214. (Pubitemid 33070220)
46. Battaglia, M., S. Gregori, R. Bacchetta, and M. G. Roncarolo. 2006. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18: 120-127. (Pubitemid 43248740)
47. Baecher-Allan, C., E. Wolf, and D. A. Hafler. 2006. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176: 4622-4631.